143 related articles for article (PubMed ID: 12783613)
1. Non-viral gene transfer therapy for cystic fibrosis.
Ziady AG; Davis PB; Konstan MW
Expert Opin Biol Ther; 2003 Jun; 3(3):449-58. PubMed ID: 12783613
[TBL] [Abstract][Full Text] [Related]
2. Gene delivery to the lungs: pulmonary gene therapy for cystic fibrosis.
Villate-Beitia I; Zarate J; Puras G; Pedraz JL
Drug Dev Ind Pharm; 2017 Jul; 43(7):1071-1081. PubMed ID: 28270008
[TBL] [Abstract][Full Text] [Related]
3. Safety and biological efficacy of an adeno-associated virus vector-cystic fibrosis transmembrane regulator (AAV-CFTR) in the cystic fibrosis maxillary sinus.
Wagner JA; Messner AH; Moran ML; Daifuku R; Kouyama K; Desch JK; Manley S; Norbash AM; Conrad CK; Friborg S; Reynolds T; Guggino WB; Moss RB; Carter BJ; Wine JJ; Flotte TR; Gardner P
Laryngoscope; 1999 Feb; 109(2 Pt 1):266-74. PubMed ID: 10890777
[TBL] [Abstract][Full Text] [Related]
4. Compacted DNA nanoparticles administered to the nasal mucosa of cystic fibrosis subjects are safe and demonstrate partial to complete cystic fibrosis transmembrane regulator reconstitution.
Konstan MW; Davis PB; Wagener JS; Hilliard KA; Stern RC; Milgram LJ; Kowalczyk TH; Hyatt SL; Fink TL; Gedeon CR; Oette SM; Payne JM; Muhammad O; Ziady AG; Moen RC; Cooper MJ
Hum Gene Ther; 2004 Dec; 15(12):1255-69. PubMed ID: 15684701
[TBL] [Abstract][Full Text] [Related]
5. Gene therapy for cystic fibrosis.
Davies JC; Alton EW
Proc Am Thorac Soc; 2010 Nov; 7(6):408-14. PubMed ID: 21030522
[TBL] [Abstract][Full Text] [Related]
6. Topical cystic fibrosis transmembrane conductance regulator gene replacement for cystic fibrosis-related lung disease.
Lee T; Southern KW
Cochrane Database Syst Rev; 2007 Apr; (2):CD005599. PubMed ID: 17443603
[TBL] [Abstract][Full Text] [Related]
7. Comparison of DNA-lipid complexes and DNA alone for gene transfer to cystic fibrosis airway epithelia in vivo.
Zabner J; Cheng SH; Meeker D; Launspach J; Balfour R; Perricone MA; Morris JE; Marshall J; Fasbender A; Smith AE; Welsh MJ
J Clin Invest; 1997 Sep; 100(6):1529-37. PubMed ID: 9294121
[TBL] [Abstract][Full Text] [Related]
8. Functional evidence of CFTR gene transfer in nasal epithelium of cystic fibrosis mice in vivo following luminal application of DNA complexes targeted to the serpin-enzyme complex receptor.
Ziady AG; Kelley TJ; Milliken E; Ferkol T; Davis PB
Mol Ther; 2002 Apr; 5(4):413-9. PubMed ID: 11945068
[TBL] [Abstract][Full Text] [Related]
9. Pre-clinical evaluation of three non-viral gene transfer agents for cystic fibrosis after aerosol delivery to the ovine lung.
McLachlan G; Davidson H; Holder E; Davies LA; Pringle IA; Sumner-Jones SG; Baker A; Tennant P; Gordon C; Vrettou C; Blundell R; Hyndman L; Stevenson B; Wilson A; Doherty A; Shaw DJ; Coles RL; Painter H; Cheng SH; Scheule RK; Davies JC; Innes JA; Hyde SC; Griesenbach U; Alton EW; Boyd AC; Porteous DJ; Gill DR; Collie DD
Gene Ther; 2011 Oct; 18(10):996-1005. PubMed ID: 21512505
[TBL] [Abstract][Full Text] [Related]
10. Adenovirus 5-fiber 35 chimeric vector mediates efficient apical correction of the cystic fibrosis transmembrane conductance regulator defect in cystic fibrosis primary airway epithelia.
Granio O; Ashbourne Excoffon KJ; Henning P; Melin P; Norez C; Gonzalez G; Karp PH; Magnusson MK; Habib N; Lindholm L; Becq F; Boulanger P; Zabner J; Hong SS
Hum Gene Ther; 2010 Mar; 21(3):251-69. PubMed ID: 19788389
[TBL] [Abstract][Full Text] [Related]
11. rAAV-CFTRΔR Rescues the Cystic Fibrosis Phenotype in Human Intestinal Organoids and Cystic Fibrosis Mice.
Vidović D; Carlon MS; da Cunha MF; Dekkers JF; Hollenhorst MI; Bijvelds MJ; Ramalho AS; Van den Haute C; Ferrante M; Baekelandt V; Janssens HM; De Boeck K; Sermet-Gaudelus I; de Jonge HR; Gijsbers R; Beekman JM; Edelman A; Debyser Z
Am J Respir Crit Care Med; 2016 Feb; 193(3):288-98. PubMed ID: 26509335
[TBL] [Abstract][Full Text] [Related]
12. Efficiency of cationic lipid-mediated transfection of polarized and differentiated airway epithelial cells in vitro and in vivo.
Jiang C; O'Connor SP; Fang SL; Wang KX; Marshall J; Williams JL; Wilburn B; Echelard Y; Cheng SH
Hum Gene Ther; 1998 Jul; 9(11):1531-42. PubMed ID: 9694152
[TBL] [Abstract][Full Text] [Related]
13. Aerosol and lobar administration of a recombinant adenovirus to individuals with cystic fibrosis. I. Methods, safety, and clinical implications.
Joseph PM; O'Sullivan BP; Lapey A; Dorkin H; Oren J; Balfour R; Perricone MA; Rosenberg M; Wadsworth SC; Smith AE; St George JA; Meeker DP
Hum Gene Ther; 2001 Jul; 12(11):1369-82. PubMed ID: 11485629
[TBL] [Abstract][Full Text] [Related]
14. Evidence for safety and efficacy of DOTAP cationic liposome mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis.
Porteous DJ; Dorin JR; McLachlan G; Davidson-Smith H; Davidson H; Stevenson BJ; Carothers AD; Wallace WA; Moralee S; Hoenes C; Kallmeyer G; Michaelis U; Naujoks K; Ho LP; Samways JM; Imrie M; Greening AP; Innes JA
Gene Ther; 1997 Mar; 4(3):210-8. PubMed ID: 9135734
[TBL] [Abstract][Full Text] [Related]
15. Polyethylenimine shows properties of interest for cystic fibrosis gene therapy.
Ferrari S; Pettenazzo A; Garbati N; Zacchello F; Behr JP; Scarpa M
Biochim Biophys Acta; 1999 Oct; 1447(2-3):219-25. PubMed ID: 10542318
[TBL] [Abstract][Full Text] [Related]
16. A double-blind, placebo controlled, dose ranging study to evaluate the safety and biological efficacy of the lipid-DNA complex GR213487B in the nasal epithelium of adult patients with cystic fibrosis.
Knowles MR; Noone PG; Hohneker K; Johnson LG; Boucher RC; Efthimiou J; Crawford C; Brown R; Schwartzbach C; Pearlman R
Hum Gene Ther; 1998 Jan; 9(2):249-69. PubMed ID: 9472784
[TBL] [Abstract][Full Text] [Related]
17. Gene therapy in cystic fibrosis.
Flotte TR; Laube BL
Chest; 2001 Sep; 120(3 Suppl):124S-131S. PubMed ID: 11555567
[TBL] [Abstract][Full Text] [Related]
18. Gene transfer to freshly isolated human respiratory epithelial cells in vitro using a replication-deficient adenovirus containing the human cystic fibrosis transmembrane conductance regulator cDNA.
Rosenfeld MA; Chu CS; Seth P; Danel C; Banks T; Yoneyama K; Yoshimura K; Crystal RG
Hum Gene Ther; 1994 Mar; 5(3):331-42. PubMed ID: 7517189
[TBL] [Abstract][Full Text] [Related]
19. Targeting the Root Cause of Cystic Fibrosis.
Trescott L; Holcomb J; Spellmon N; Mcleod C; Aljehane L; Sun F; Li C; Yang Z
Curr Drug Targets; 2015; 16(9):933-44. PubMed ID: 25316272
[TBL] [Abstract][Full Text] [Related]
20. Vector-specific complementation profiles of two independent primary defects in cystic fibrosis airways.
Zhang Y; Jiang Q; Dudus L; Yankaskas JR; Engelhardt JF
Hum Gene Ther; 1998 Mar; 9(5):635-48. PubMed ID: 9551612
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
